Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.750
+0.010 (1.35%)
Dec 26, 2024, 4:00 PM EST
Fresh Tracks Therapeutics Revenue
In the year 2023, Fresh Tracks Therapeutics had annual revenue of $8.01M with 15.31% growth.
Revenue
8.01M
Revenue Growth
+15.31%
P/S Ratio
0.50
Revenue / Employee
2.00M
Employees
4
Market Cap
4.42M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Fresh Tracks Therapeutics News
- 21 days ago - Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company - PRNewsWire
- 6 months ago - Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company - GlobeNewsWire
- 11 months ago - Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15th - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Announces Plan to Hold New Special Meeting of Stockholders on February 15th - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Announces Listing on OTC Pink Market - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders - GlobeNewsWire
- 1 year ago - Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders - GlobeNewsWire